Showing 101-120 of 503 for: Cochrane Systematic Reviews > Neurologic 
- Cholinesterase inhibitors for Parkinson's disease dementia
Cochrane Systematic Reviews, 5-May-2008
The loss of cholinergic, dopaminergic and noradrenergic innervations seen in Parkinson's Disease Dementia (PDD) suggest a potential role for cholinesterase inhibitors. Concerns have been expressed about a theoretical worsening of Parkinson's disease relat
- Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis or motor neuron disease
Cochrane Systematic Reviews, 9-Nov-2011
Amyotrophic lateral sclerosis, also known as motor neuron disease, is a fatal neuromuscular disease characterized by progressive muscle weakness resulting in paralysis. It might be treated with ciliary neurotrophic factor. This is an updated review. An up
- Clobazam as an add-on in the management of refractory epilepsy
Cochrane Systematic Reviews, 12-Apr-2011
Epilepsy effects approximately 1% of the population, with up to 30% of patients continuing to have seizures despite antiepileptic drug treatment.
- Coenzyme Q10 for Parkinson's disease
Cochrane Systematic Reviews, 16-Apr-2012
A number of preclinical studies in both in vitro and in vivo models of Parkinson's disease have demonstrated that coenzyme Q10 can protect the nigrostriatal dopaminergic system. Some clinical trials have looked at the neuroprotective effects of coenzyme Q
- Cognitive behaviour therapy for chronic fatigue syndrome in adults
Cochrane Systematic Reviews, 12-Feb-2009
Chronic fatigue syndrome (CFS) is a common, debilitating and serious health problem. Cognitive behaviour therapy (CBT) may help to alleviate the symptoms of CFS.
- Cognitive behavioural interventions for sleep problems in adults aged 60+
Cochrane Systematic Reviews, 11-Nov-2008
The prevalence of sleep problems in adulthood increases with age. While not all sleep changes are pathological in later life, severe disturbances may lead to depression, cognitive impairments, deterioration of quality of life, significant stresses for car
- Cognitive training and cognitive rehabilitation for mild to moderate Alzheimer's disease and vascular dementia
Cochrane Systematic Reviews, 22-May-2013
Cognitive impairments, particularly memory problems, are a defining feature of the early stages of Alzheimer's disease (AD) and vascular dementia. Cognitive training and cognitive rehabilitation are specific interventional approaches designed to address d
- Combined vitamin B6-magnesium treatment in autism spectrum disorder
Cochrane Systematic Reviews, 11-Nov-2008
The use of mega-vitamin intervention began in the 1950s with the treatment of schizophrenic patients. Pyroxidine (vitamin B6) was first used with children diagnosed with "autism syndrome" when speech and language improvement was observed in some children
- Common antiepileptic drugs in pregnancy in women with epilepsy
Cochrane Systematic Reviews, 17-Dec-2015
The potential adverse effects of antiepileptic drug (AED) exposure in pregnancy have been well recognised but the relative risks of specific antiepileptic drug exposures remain poorly understood.
- Comparison of speech and language therapy techniques for speech problems in Parkinson's disease
Cochrane Systematic Reviews, 17-Jul-2012
Patients with Parkinson's disease commonly suffer from speech and voice difficulties such as impaired articulation and reduced loudness. Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques
- Constraint-induced movement therapy for upper extremities in people with stroke
Cochrane Systematic Reviews, 7-Oct-2015
In people who have had a stroke, upper limb paresis affects many activities of daily life. Reducing disability is therefore a major aim of rehabilitative interventions. Despite preserving or recovering movement ability after stroke, sometimes people do no
- Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy
Cochrane Systematic Reviews, 12-Nov-2008
Children with hemiplegic cerebral palsy learn strategies to manage daily tasks (for example play) using one hand and often the affected limb is disregarded or not used. Constraint-induced movement therapy (CIMT) is emerging as a treatment approach for use
- Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea
Cochrane Systematic Reviews, 26-Jun-2014
Continuous positive airway pressure (CPAP) is the mainstay of therapy for moderate to severe obstructive sleep apnoea (OSA). However, compliance with CPAP has been less than ideal. There are many different CPAP interfaces now available for the treatment o
- Continuous positive airways pressure for obstructive sleep apnoea in adults
Cochrane Systematic Reviews, 1-Jul-2008
Obstructive sleep apnoea is the periodic reduction (hypopnoea) or cessation (apnoea) of breathing due to narrowing or occlusion of the upper airway during sleep. The main symptom is daytime sleepiness and it has been suggested it is linked to premature de
- Cooling for cerebral protection during brain surgery
Cochrane Systematic Reviews, 26-Jan-2015
Patients undergoing neurosurgery are at risk of cerebral ischaemia with resultant cerebral hypoxia and neuronal cell death. This can increase both the risk of mortality and long term neurological disability. Induced hypothermia has been shown to reduce th
- Cooling for newborns with hypoxic ischaemic encephalopathy
Cochrane Systematic Reviews, 26-Feb-2013
Newborn animal studies and pilot studies in humans suggest that mild hypothermia following peripartum hypoxia-ischaemia in newborn infants may reduce neurological sequelae without adverse effects.
- Corticosteroids for acute bacterial meningitis
Cochrane Systematic Reviews, 15-Mar-2016
In experimental studies, the outcome of bacterial meningitis has been related to the severity of inflammation in the subarachnoid space. Corticosteroids reduce this inflammatory response.
- Corticosteroids for acute traumatic brain injury
Cochrane Systematic Reviews, 11-May-2009
Traumatic brain injury is a leading cause of death and disability. Corticosteroids have been widely used in treating people with traumatic brain injury.
- Corticosteroids for Bell's palsy (idiopathic facial paralysis)
Cochrane Systematic Reviews, 16-Feb-2010
Inflammation and oedema of the facial nerve are implicated in causing Bell's palsy. Corticosteroids have a potent anti-inflammatory action which should minimise nerve damage.
- Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 23-Dec-2014
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a progressive or relapsing and remitting paralysing illness probably due to an autoimmune response which should benefit from corticosteroids. Non-randomised studies suggest that corticost
